Overview
Key Metrics Quarterly
P&L
Balance Sheet
Cash Flows
Ratios
Shareholding
Documents
About
Bliss GVS Pharma Limited engages in the development, manufacturing and marketing of pharmaceutical formulations in India and internationally. The company offers anti-diabetic, anti-infective, anti-inflammatory, antifungal, antihemorrhoidal, antimalarial, antiseptic, cardiovascular, dermatological, gastrointestinal, gynaecology, neoro/cns, ophthalmic, otc drugs, respiratory, urology, and supplementary drug products, as well as engages in pain management services. It exports its products. Bliss GVS Pharma Limited was incorporated in 1984 and is based in Mumbai, India.
Key Metrics
as of Sep 2026
Market Cap 7,131 Cr
P/E 51.80
Div Yield 0.22 %
Book Value βΉ113.00
52w High βΉ671.00
52w Low βΉ118.00
Face Value βΉ1.00
Quarterly Results
Rs. Crores Β· hover row for definition
Metric
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Jun 2023
Sales
286.00
257.00
218.00
244.00
207.00
198.00
210.00
218.00
184.00
198.00
201.00
212.00
160.00
Expenses
209.00
213.00
183.00
201.00
166.00
177.00
181.00
176.00
149.00
170.00
157.00
158.00
135.00
Operating Profit
76.00
44.00
35.00
43.00
41.00
21.00
30.00
41.00
34.00
28.00
44.00
54.00
24.00
OPM %
27.00
17.00
16.00
18.00
20.00
11.00
14.00
19.00
19.00
14.00
22.00
26.00
15.00
Other Income
10.00
11.00
16.00
8.00
35.00
12.00
15.00
5.00
4.00
-24.00
5.00
13.00
5.00
Depreciation
10.00
9.00
8.00
8.00
8.00
8.00
8.00
7.00
7.00
7.00
7.00
6.00
6.00
Interest
1.00
2.00
1.00
3.00
5.00
2.00
1.00
4.00
2.00
2.00
2.00
1.00
1.00
Profit before tax
75.00
45.00
41.00
41.00
63.00
23.00
36.00
36.00
30.00
-4.00
40.00
59.00
22.00
Tax %
32.00
18.00
39.00
30.00
30.00
29.00
29.00
28.00
26.00
24.00
27.00
27.00
34.00
Net Profit
51.00
37.00
25.00
29.00
44.00
17.00
26.00
26.00
22.00
-5.00
29.00
43.00
14.00
EPS in Rs
4.72
3.36
2.20
2.58
4.08
1.47
2.26
2.31
1.97
-0.87
2.64
4.05
1.41
Profit & Loss
Annual Β· Rs. Crores
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Sales
927.00 810.00 770.00 752.00 747.00 577.00 689.00 899.00 815.00 798.00 547.00 407.00
Expenses
760.00 683.00 620.00 634.00 629.00 471.00 566.00 739.00 618.00 596.00 391.00 304.00
Operating Profit
168.00 127.00 151.00 117.00 118.00 107.00 123.00 160.00 197.00 203.00 156.00 103.00
OPM %
18.00 16.00 20.00 16.00 16.00 18.00 18.00 18.00 24.00 25.00 29.00 25.00
Other Income
67.00 36.00 0.00 18.00 -42.00 20.00 26.00 35.00 -8.00 12.00 24.00 20.00
Interest
12.00 8.00 7.00 10.00 5.00 6.00 8.00 4.00 23.00 20.00 19.00 16.00
Depreciation
33.00 29.00 26.00 19.00 17.00 17.00 13.00 9.00 21.00 20.00 13.00 11.00
Profit before tax
190.00 126.00 117.00 106.00 54.00 104.00 129.00 182.00 145.00 175.00 148.00 96.00
Tax %
29.00 28.00 30.00 28.00 57.00 29.00 26.00 30.00 39.00 36.00 32.00 36.00
Net Profit
135.00 90.00 82.00 77.00 23.00 74.00 95.00 127.00 89.00 113.00 100.00 61.00
EPS in Rs
12.21 8.00 7.21 6.80 1.45 6.64 9.43 11.99 5.70 7.95 8.00 5.81
Dividend Payout %
4.00 6.00 7.00 7.00 34.00 8.00 5.00 8.00 18.00 8.00 6.00 12.00
Balance Sheet
Annual Β· Rs. Crores β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Equity Capital
11.00 11.00 10.00 10.00 10.00 10.00 10.00 10.00 10.00 10.00 10.00 10.00
Reserves
1,182.00 1,040.00 957.00 873.00 808.00 798.00 725.00 636.00 526.00 476.00 402.00 327.00
Borrowings
22.00 88.00 100.00 102.00 109.00 122.00 126.00 102.00 118.00 225.00 132.00 160.00
Other Liabilities
278.00 163.00 145.00 171.00 181.00 147.00 168.00 157.00 206.00 311.00 218.00 166.00
Total Liabilities
1,492.00 1,301.00 1,212.00 1,157.00 1,109.00 1,077.00 1,030.00 905.00 860.00 1,023.00 762.00 662.00
Fixed Assets
459.00 406.00 370.00 379.00 281.00 234.00 242.00 146.00 143.00 305.00 225.00 234.00
CWIP
6.00 21.00 8.00 3.00 22.00 2.00 0.00 47.00 0.00 4.00 9.00 0.00
Investments
5.00 4.00 4.00 8.00 2.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Assets
1,022.00 871.00 830.00 768.00 803.00 840.00 788.00 712.00 717.00 714.00 527.00 428.00
Total Assets
1,492.00 1,301.00 1,212.00 1,157.00 1,109.00 1,077.00 1,030.00 905.00 860.00 1,023.00 762.00 662.00
Cash Flows
Annual Β· Rs. Crores β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Cash from Operating Activity
139.00 106.00 103.00 34.00 135.00 64.00 47.00 40.00 18.00 289.00 113.00 38.00
Cash from Investing Activity
-38.00 -75.00 -83.00 -6.00 -103.00 -45.00 -40.00 -79.00 48.00 -249.00 -50.00 -29.00
Cash from Financing Activity
-89.00 -30.00 -21.00 -25.00 -24.00 -21.00 -6.00 17.00 -76.00 -10.00 -40.00 -42.00
Net Cash Flow
11.00 0.00 -1.00 3.00 9.00 -2.00 0.00 -22.00 -10.00 30.00 23.00 -34.00
Free Cash Flow
84.00 33.00 75.00 -59.00 63.00 55.00 -12.00 2.00 -7.00 186.00 101.00 5.00
CFO/OP %
108.00 112.00 91.00 67.00 143.00 87.00 69.00 -8.00 29.00 160.00 101.00 45.00
Ratios
Annual Β· Days / % β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Debtor Days
204.00 198.00 192.00 187.00 192.00 293.00 290.00 187.00 134.00 116.00 201.00 222.00
Inventory Days
129.00 111.00 113.00 94.00 116.00 110.00 64.00 46.00 55.00 50.00 55.00 69.00
Days Payable
89.00 63.00 58.00 79.00 86.00 82.00 75.00 47.00 55.00 100.00 153.00 165.00
Cash Conversion Cycle
244.00 246.00 247.00 202.00 221.00 321.00 279.00 186.00 134.00 67.00 102.00 126.00
Working Capital Days
214.00 198.00 207.00 192.00 179.00 264.00 232.00 154.00 135.00 -10.00 84.00 105.00
ROCE %
17.00 12.00 14.00 12.00 14.00 12.00 18.00 26.00 27.00 29.00 31.00 23.00
Shareholding Pattern
% holding β latest first
Quarterly
Yearly
Holder
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Promoters
35.01
35.36
35.36
35.39
35.44
35.29
35.10
34.82
34.90
34.97
34.97
35.06
FIIs
8.07
10.45
14.54
13.27
12.65
13.18
13.51
12.13
13.24
14.74
15.35
16.31
DIIs
9.46
5.04
5.78
5.98
6.54
6.55
6.55
6.56
6.58
6.59
6.60
6.61
Public
47.45
49.15
44.32
45.36
45.37
44.98
44.84
46.49
45.27
43.71
43.08
42.00
No. of Shareholders
46,767
44,874
43,380
44,461
46,707
49,517
49,558
52,937
44,737
45,157
40,758
43,234
Corporate Actions
27 records
Back to all stocks